NCT03033810

Brief Summary

The study will compare two invasive methods (FFR -fractional flow reserve and iFR-instantaneous wave free ratio) for assessment of hemodynamic impact of coronary stenosis on myocardial perfusion. There is a very good correlation between these methods for the assessment of hemodynamic significance in a broad spectrum of lesions. However, this correlation decreases significantly near the cut off points for each method. The investigators will try to find possible explanations for these differences by detailed morphology assessment of coronary stenosis using optical coherence tomography (OCT), analysis of gene polymorphisms that play a role in vasodilatation, and by shear stress analysis. The head-to-head comparison between FFR and iFR is not simple, because there is no "gold standard" for assessment of hemodynamic significance. Studies comparing these methods have used hyperemic stenosis resistance (HSR). For this kind of measurement it is necessary to measure the speed of blood flow. This is usually done by a Doppler analysis of flow. Unfortunately, the Doppler signal can yield many artificial or erroneous indicators, and obtaining a good quality signal is frequently time-consuming. These are the reasons that HSR has not been used in routine practice. The investigators have developed a new console and software that can provide real time analysis of the Doppler signal. It allows us to easily measure HSR, and to differentiate between the FFR and iFR measures through intrabeat analysis of microvascular resistance (lowest microvascular resistance is an essential condition for proper pressure measurement). Using this tool, it is possible to automatically identify the point of lowest microvascular resistance during each cardiac beat. The pressure gradient can then be measured at that point. This approach can eliminate almost all uncertainties in assessment of the pressure gradient produced by coronary stenosis. This tool can potentially improve the existing methods used to precisely reveal a significant stenosis. This should increase the number of hemodynamic guided procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

January 8, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 27, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 27, 2017

Status Verified

January 1, 2017

Enrollment Period

2.4 years

First QC Date

January 8, 2017

Last Update Submit

January 24, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of endothelial dysfunction, plaque superficial irregularities and gene polymorphisms in patients with screpancies between FFR and iFR during functional assessments of coronary stenosis.

    Endothelial dysfunction measured by EndoPAT, plaque superficial irregularities measured by OCT and gene polymorphisms in ENOS and HO-1 can be different in patients with discrepancy between FFR and iFR compared to known results from patients with coronary artery disease.

    2017-2019

Secondary Outcomes (2)

  • To use a new software to determine which of two methods for the functional assessment of coronary stenosis (FFR and iFR) perform their measurements during a lower level of microvascular resistance.

    2017-2019

  • To develop a new version of aforementioned software for the detection of microvascular resistance level, based only on intracoronary pressures without flow analysis

    2017-2019

Study Arms (1)

Consecutive patients with FFR and iFR

Patients with stable angina pectoris with suitable for coronary angiography will be suitable for the study

Device: Fractional flow reserve and instantaneous wave-free ratio

Interventions

1. To explain discrepancies between FFR and iFR using demographic, morphological, genetic and functional indices. 2. The development of software for the automatic detection of the lowest point of microvascular resistance.

Consecutive patients with FFR and iFR

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with stable angina pectoris indicated for lesion hemodynamic assessment for bordeline stensois found during coronary angiography

You may qualify if:

  • Stable angina pectoris
  • Age 18-80 years
  • Signed inform consent
  • Coronary arteries without severe tortuosity and calcifications
  • Normal blood flow in coronary arteries (TIMI flow III)
  • Coronary artery stenosis less than 80% during CAG

You may not qualify if:

  • Hemodynamic instability, cardio-pulmonary resuscitation in a same day
  • Thrombosis in a target coronary artery visible during angiography
  • Patients after or with planned coronary artery bypass grafting
  • Severe bronchial asthma or atrio-ventricular block higher than first degree (contraindication for adenosine administration)
  • Renal insufficiency with creatinine level more than 180 umol/l
  • Known allergy to iodine contrast
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

II. interni klinika VFN

Prague, 12808, Czechia

RECRUITING

Related Publications (22)

  • Park SJ, Kang SJ, Ahn JM, Shim EB, Kim YT, Yun SC, Song H, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Mintz GS, Park SW. Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv. 2012 Oct;5(10):1029-36. doi: 10.1016/j.jcin.2012.07.007.

    PMID: 23078732BACKGROUND
  • Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NH, Siebes M, Spaan JA; American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006 Sep 19;114(12):1321-41. doi: 10.1161/CIRCULATIONAHA.106.177276. Epub 2006 Aug 28.

    PMID: 16940193BACKGROUND
  • Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009 Jan 15;360(3):213-24. doi: 10.1056/NEJMoa0807611.

    PMID: 19144937BACKGROUND
  • De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, Jagic N, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd K, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Limacher A, Nuesch E, Juni P; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014 Sep 25;371(13):1208-17. doi: 10.1056/NEJMoa1408758. Epub 2014 Sep 1.

    PMID: 25176289BACKGROUND
  • Kral A, Kovarnik T, Kralik L, Skalicka H, Horak J, Mintz GS, Uhrova J, Sonka M, Wahle A, Downe R, Aschermann M, Martasek P, Linhart A. Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosis. Folia Biol (Praha). 2011;57(5):182-90. doi: 10.14712/fb2011057050182.

    PMID: 22123460BACKGROUND
  • Meuwissen M, Chamuleau SA, Siebes M, Schotborgh CE, Koch KT, de Winter RJ, Bax M, de Jong A, Spaan JA, Piek JJ. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation. 2001 Jan 16;103(2):184-7. doi: 10.1161/01.cir.103.2.184.

    PMID: 11208673BACKGROUND
  • Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol. 2007 Jun 26;49(25):2379-93. doi: 10.1016/j.jacc.2007.02.059. Epub 2007 Jun 8.

    PMID: 17599600BACKGROUND
  • Sen S, Escaned J, Malik IS, Mikhail GW, Foale RA, Mila R, Tarkin J, Petraco R, Broyd C, Jabbour R, Sethi A, Baker CS, Bellamy M, Al-Bustami M, Hackett D, Khan M, Lefroy D, Parker KH, Hughes AD, Francis DP, Di Mario C, Mayet J, Davies JE. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol. 2012 Apr 10;59(15):1392-402. doi: 10.1016/j.jacc.2011.11.003. Epub 2011 Dec 7.

    PMID: 22154731BACKGROUND
  • Petraco R, van de Hoef TP, Nijjer S, Sen S, van Lavieren MA, Foale RA, Meuwissen M, Broyd C, Echavarria-Pinto M, Foin N, Malik IS, Mikhail GW, Hughes AD, Francis DP, Mayet J, Di Mario C, Escaned J, Piek JJ, Davies JE. Baseline instantaneous wave-free ratio as a pressure-only estimation of underlying coronary flow reserve: results of the JUSTIFY-CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic Characteristics of Basal and Hyperemic Indices of Functional Lesion Severity-Coronary Flow Reserve). Circ Cardiovasc Interv. 2014 Aug;7(4):492-502. doi: 10.1161/CIRCINTERVENTIONS.113.000926. Epub 2014 Jul 1.

    PMID: 24987048BACKGROUND
  • van de Hoef TP, Nolte F, EchavarrIa-Pinto M, van Lavieren MA, Damman P, Chamuleau SA, Voskuil M, Verberne HJ, Henriques JP, van Eck-Smit BL, Koch KT, de Winter RJ, Spaan JA, Siebes M, Tijssen JG, Meuwissen M, Piek JJ. Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment. Heart. 2014 Jun;100(12):951-9. doi: 10.1136/heartjnl-2013-305124. Epub 2014 Apr 11.

    PMID: 24727867BACKGROUND
  • Wahle A, Prause GP, von Birgelen C, Erbel R, Sonka M. Fusion of angiography and intravascular ultrasound in vivo: establishing the absolute 3-D frame orientation. IEEE Trans Biomed Eng. 1999 Oct;46(10):1176-80. doi: 10.1109/10.790492.

    PMID: 10513120BACKGROUND
  • Wahle A, Prause PM, DeJong SC, Sonka M. Geometrically correct 3-D reconstruction of intravascular ultrasound images by fusion with biplane angiography--methods and validation. IEEE Trans Med Imaging. 1999 Aug;18(8):686-99. doi: 10.1109/42.796282.

    PMID: 10534051BACKGROUND
  • Perktold K, Hofer M, Rappitsch G, Loew M, Kuban BD, Friedman MH. Validated computation of physiologic flow in a realistic coronary artery branch. J Biomech. 1998 Mar;31(3):217-28. doi: 10.1016/s0021-9290(97)00118-8.

    PMID: 9645536BACKGROUND
  • Ethier CR. Computational modeling of mass transfer and links to atherosclerosis. Ann Biomed Eng. 2002 Apr;30(4):461-71. doi: 10.1114/1.1468890.

    PMID: 12085998BACKGROUND
  • Weydahl ES, Moore JE. Dynamic curvature strongly affects wall shear rates in a coronary artery bifurcation model. J Biomech. 2001 Sep;34(9):1189-96. doi: 10.1016/s0021-9290(01)00051-3.

    PMID: 11506789BACKGROUND
  • Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004 Dec 7;44(11):2137-41. doi: 10.1016/j.jacc.2004.08.062.

    PMID: 15582310BACKGROUND
  • Jeremias A, Maehara A, Genereux P, Asrress KN, Berry C, De Bruyne B, Davies JE, Escaned J, Fearon WF, Gould KL, Johnson NP, Kirtane AJ, Koo BK, Marques KM, Nijjer S, Oldroyd KG, Petraco R, Piek JJ, Pijls NH, Redwood S, Siebes M, Spaan JAE, van 't Veer M, Mintz GS, Stone GW. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol. 2014 Apr 8;63(13):1253-1261. doi: 10.1016/j.jacc.2013.09.060. Epub 2013 Nov 6.

    PMID: 24211503BACKGROUND
  • Eshtehardi P, McDaniel MC, Suo J, Dhawan SS, Timmins LH, Binongo JN, Golub LJ, Corban MT, Finn AV, Oshinski JN, Quyyumi AA, Giddens DP, Samady H. Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease. J Am Heart Assoc. 2012 Aug;1(4):e002543. doi: 10.1161/JAHA.112.002543. Epub 2012 Aug 24.

    PMID: 23130168BACKGROUND
  • Campbell IC, Timmins LH, Giddens DP, Virmani R, Veneziani A, Rab ST, Samady H, McDaniel MC, Finn AV, Taylor WR, Oshinski JN. Computational Fluid Dynamics Simulations of Hemodynamics in Plaque Erosion. Cardiovasc Eng Technol. 2013 Dec;4(4):10.1007/s13239-013-0165-3. doi: 10.1007/s13239-013-0165-3.

    PMID: 24223678BACKGROUND
  • Finet G, Huo Y, Rioufol G, Ohayon J, Guerin P, Kassab GS. Structure-function relation in the coronary artery tree: from fluid dynamics to arterial bifurcations. EuroIntervention. 2010 Dec;6 Suppl J:J10-5. doi: 10.4244/EIJV6SUPJA3. No abstract available.

    PMID: 21930472BACKGROUND
  • Kovarnik T, Hitoshi M, Kral A, Jerabek S, Zemanek D, Kawase Y, Omori H, Tanigaki T, Pudil J, Vodzinska A, Branny M, Stipal R, Kala P, Mrozek J, Porzer M, Grezl T, Novobilsky K, Mendiz O, Kopriva K, Mates M, Chval M, Chen Z, Martasek P, Linhart A; FiGARO trial investigators. Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study. J Am Heart Assoc. 2022 May 3;11(9):e021490. doi: 10.1161/JAHA.121.021490. Epub 2022 May 3.

  • Jerabek S, Zemanek D, Pudil J, Bayerova K, Kral A, Kopriva K, Kawase Y, Omori H, Tanigaki T, Chen Z, Vodzinska A, Branny M, Matsuo H, Mates M, Sonka M, Kovarnik T. Endothelial dysfunction assessed by digital tonometry and discrepancy between fraction flow reserve and instantaneous wave free ratio. Acta Cardiol. 2020 Aug;75(4):323-328. doi: 10.1080/00015385.2019.1586089. Epub 2019 Apr 4.

Biospecimen

Retention: SAMPLES WITH DNA

Genetic analysis of polymorphisms in gene for Hemoxygenase-1 and endothelial nitric oxide synthase. Patient's DNA will be isolated from peripheral blood leukocytes using standard techniques.

Central Study Contacts

Tomas Kovarnik, MD, PhD

CONTACT

David Zemanek, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The Head of Invasive Cardiology Dpt.

Study Record Dates

First Submitted

January 8, 2017

First Posted

January 27, 2017

Study Start

January 1, 2017

Primary Completion

June 1, 2019

Study Completion

December 1, 2019

Last Updated

January 27, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations